United Therapeutics Corporation
|
|||
| Mailing Address: | 1826 R Street, NW Washington, District of Columbia 20009 |
Head Office Address: | 2 Davis Drive Research Triangle Park, North Carolina 27709 |
| Contact Name: | Naomi Morisawa De Koven | Principal Regulator: | |
| Business e-mail address: | Short Form Prospectus Issuer: | No | |
| Telephone Number: | 416 601-7831 | Reporting Jurisdictions: | British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland, Other than Canada |
| Fax Number: | 416 868-1862 | Stock Exchange: | TSX |
| Date of Formation: | Jun 26 1996 | Stock Symbol: | |
| Jurisdiction Where Formed: | Delaware | Auditor: | KPMG Peat Marwick LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | Transfer Agent: | Montreal Trust Company of Canada | |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | $5,000,001 to $25,000,000 |
|
